How are GLP-1 medications changing the way diabetes is managed today? In this episode, Gary Scheiner—Certified Diabetes Care and Education Specialist and clinical director of Integrated Diabetes Services—breaks down the science, benefits, and real-world impact of today’s most talked-about diabetes drugs, including Ozempic and Mounjaro.
Living with type 1 diabetes since 1985, Gary combines decades of clinical expertise with personal experience to offer a clear, practical perspective on blood sugar management, insulin therapy, and evolving treatment options.
He’s also the author of several foundational books, including Think Like a Pancreas, Get Control of Your Blood Sugar, and The Ultimate Guide to Accurate Carb Counting, and is a frequent speaker at national and international diabetes conferences.
In this conversation, we explore:
Whether you’re managing diabetes or exploring the latest treatment options, this episode delivers valuable insights into modern, evidence-based care.
Follow Gary Scheiner on LinkedIn to stay updated on his work.
Episode also available on Apple Podcasts: https://apple.co/38oMlMr
Keep up with Gary Scheiner socials here:
Instagram: https://www.instagram.com/integrated_diabetes_services/
Youtube: https://www.youtube.com/@integrateddiabetesservices
Facebook: https://www.facebook.com/gary.scheiner/
🛍️ Recommended Products & Reads from This Episode:
Note: These are affiliate links. If you make a purchase through them, we may earn a small commission at no extra cost to you. It helps support the podcast. Thank you!
Podcast: Play in new window | Download | Embed